Abstract:Bladder cancer is among the ten most prevalent cancer types worldwide, and its prognosis has not improved significantly in the past three decades because of cognitive limitations in the molecular mechanisms that drive the malignant progression of bladder cancer. Therefore, there is an urgent need to identify new therapeutic drugs or molecular targets to improve the prognosis of patients with bladder cancer. SC66, a novel allosteric inhibitor of AKT, has recently been reported to exert potent anticancer effects on various cancer cells. However, the mechanisms underlying its anticancer effects in bladder cancer remain largely unknown. Consequently, this study aimed to conduct a series of molecular and cellular biology experiments to verify the anticancer effect and potential mechanism of action of SC66 in bladder cancer in vitro. A xenograft tumor model was established to confirm its anticancer role in vivo. Our results showed that SC66 inhibited cell proliferation, triggered mitochondria-mediated apoptosis, and initiated autophagy in bladder cancer cells dose-dependently. In addition, our results suggested that SC66-caused apoptosis and autophagy were endoplasmic reticulum stress-dependent. Interestingly, the activation of autophagy can partially protect bladder cancer cells from apoptosis under endoplasmic reticulum stress induced by SC66 treatment. This study shows that SC66 exerts its anticancer impact on bladder cancer by inhibiting cell proliferation and inducing apoptosis. It also reveals that inhibiting autophagy can increase the cytotoxic effects of SC66 in bladder cancer. Overall, this is the first study on the anticancer effect of SC66 mediated by the endoplasmic reticulum stress pathway and the first report on the AKT-independent anticancer mechanism of SC66 in bladder cancer. Conclusively, exploring the relationship between apoptosis, autophagy, and endoplasmic reticulum stress induced by SC66 indicates that SC66 is a promising novel agent for patients with bladder cancer.

Activation of Type 4 Metabotropic Glutamate Receptor Promotes Cell Apoptosis and Inhibits Proliferation in Bladder Cancer.

Activity of Metabotropic Glutamate Receptor 4 Suppresses Proliferation and Promotes Apoptosis with Inhibition of Gli-1 in Human Glioblastoma Cells.

Testicular Nuclear Receptor 4 Regulates Proliferation and Apoptosis of Bladder Cancer <i>via</i> Bcl-2

Metabotropic Glutamate Receptor 8 Activation Promotes the Apoptosis of Lung Carcinoma A549 Cells in Vitro

Expression of MAP4K4 in Bladder Cancer and Its Biological Effect on Human Bladder Cancer T24 Cells

Downregulation of Angiogenin Inhibits the Growth and Induces Apoptosis in Human Bladder Cancer Cells Through Regulating AKT/mTOR Signaling Pathway.

Activation of Glucocorticoid Receptor Inhibits the Stem-Like Properties of Bladder Cancer Via Inactivating the Β-Catenin Pathway.

Overexpression of Mir-340 Inhibits Cell Proliferation and Induces Apoptosis of Human Bladder Cancer Via Targeting Glut-1

Mir-1-3p Contributes to Cell Proliferation and Invasion by Targeting Glutaminase in Bladder Cancer Cells

Activation of cyclic AMP/PKA pathway inhibits bladder cancer cell invasion by targeting MAP4-dependent microtubule dynamics.

Activation of Type 4 Metabotropic Glutamate Receptor Regulates Proliferation and Neuronal Differentiation in a Cultured Rat Retinal Progenitor Cell Through the Suppression of the Camp/pten/akt Pathway.

Mir-1307-5p Suppresses Proliferation and Tumorigenesis of Bladder Cancer Via Targeting MDM4 and the Hippo Signaling Pathway

Activation of metabotropic glutamate receptor 4 regulates proliferation and neural differentiation in neural stem/progenitor cells of the rat subventricular zone and increases phosphatase and tensin homolog protein expression

Glaucocalyxin A Induces G2/M Cell Cycle Arrest and Apoptosis Through the PI3K/Akt Pathway in Human Bladder Cancer Cells.

A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer

TM4SF1 Regulates Apoptosis, Cell Cycle and ROS Metabolism Via the PPARγ-SIRT1 Feedback Loop in Human Bladder Cancer Cells.

Inhibition of KDM4A restricts SQLE transcription and induces oxidative stress imbalance to suppress bladder cancer

Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer

RNA Interference-Mediated Vascular Endothelial Growth Factor-C Reduction Suppresses Malignant Progression and Enhances Mitomycin C Sensitivity of Bladder Cancer T24 Cells

UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT

Inhibition of autophagy can promote the apoptosis of bladder cancer cells induced by SC66 through the endoplasmic reticulum stress pathway